CHRS
Coherus Onco (CHRS)
NASDAQ
$1.18+$0.02 (+2.07%)
Price as of Oct 02, 2026 5:26 PM EDT
  • $179.2M
    Market Cap
  • -30.12%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

N/A
Valuation
CHRS
vs History
vs S&P 500
Profitability
1
Growth
0
Low Earnings Volatility
5

Momentum Score

Score: 28
Valuation
CHRS
vs History
vs S&P 500
3-Month Momentum
-2.14%
12-Month Momentum
-15.43%
3-Month Risk Adjusted Momentum
-6.94%
12-Month Risk Adjusted Momentum
-20.05%

True Yield

N/A
Valuation
CHRS
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
-0.05%

Financial Health Score

N/A
Valuation
CHRS
vs History
vs S&P 500
Ohlson's O-Score
8